Shiwei Yang

Dr. Shiwei Yang

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2021 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
HYHao Yi-Dan
Hao Yi-Dan
ZYZhao Ying-Xin
Zhao Ying-Xin
SYShiwei Yang
Shiwei Yang
ZYZhou Yu-Jie
Zhou Yu-Jie
The purpose of this review is to bridge the gap between clinical and basic research through providing a comprehensive and concise description of the cellular and molecular aspects of cardioprotective mechanisms and a critical evaluation of the clinical evidence of high-energy phosphates (HEPs) in ischemic heart disease (IHD). According to the well-documented physiological, pathophysiological and pharmacological properties of HEPs, exogenous creatine phosphate (CrP) may be considered as an ideal metabolic regulator. It plays cardioprotection roles from upstream to downstream of myocardial ischemia through multiple complex mechanisms, including but not limited to replenishment of cellular energy. Although exogenous CrP administration has not been shown to improve long-term survival, the beneficial effects on multiple secondary but important outcomes and short-term survival are concordant with its pathophysiological and pharmacological effects. There is urgent need for high-quality multicentre RCTs to confirm long-term survival improvement in the future.

1 June 2023 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
JSJiayin Sun
Jiayin Sun
LYLichuang Yuan
Lichuang Yuan
HYHailiang Yu
Hailiang Yu
YYYanzhao Yang
Yanzhao Yang
ZZZhiming Zhou
Zhiming Zhou
SYShiwei Yang
Shiwei Yang
Background: Contrast-induced encephalopathy (CIE) is considered as an uncommon complication following cardiac catheterization. Due to the varied manifestations, CIE has no formal diagnostic criteria. In fact, the incidence of CIE may be greatly underestimated because of the difficulty in its differential diagnosis with other cerebrovascular complications. Thus, making a flow diagram according to patients’ clinical symptoms and examinations after cardiac catheterization to help clinicians diagnose CIE is important and needed. Case presentation: In this report, we describe a case of probable CIE in a 66-year-old Chinese man with hypertension who underwent cardiac catheterization with stents placement in the bifurcation lesion, during which 80 ml iopromide contrast was used. About 2 h following the procedure, the patient lost his consciousness suddenly and suffered from a status epilepticus. Malignant arrhythmias were not found through continuous electrocardiogram monitoring, but mild ST-segment elevation was displayed in leads I and aVL. The echocardiography, plasma glucose and electrolyte levels were normal. Emergency re-angiography with percutaneous transluminal coronary angioplasty was performed in the culprit lesion, which involved 60 ml iopromide contrast. However, the patient remained unconsciousness and epilepticus. Non-contrast computed tomography (CT) of the head showed cortical and subarachnoid enhancement as well as prolonged retention of contrast media in the middle cerebral artery. With supportive treatment of intravenous hydration, sedative and dehydrant, the patient recovered 3 h later and finally discharged without any neurological deficits. Conclusions: CIE is an acute reversible encephalopathy induced by contrast media. It is exceptionally challenging to make the diagnosis of CIE following cardiac catheterization since there is a lack of consensus on the definition of CIE. Via this case we reviewed the related literatures, through which a flow diagram of the differential diagnosis and clinical decision making was given, which could help to differentiate CIE from other neurological complications following cardiac catheterization.

1 June 2026 in Journal of Inflammation Research
Verified
Journal Article
Open access
SYShiwei Yang
Shiwei Yang
SQShuchang Qi
Shuchang Qi
MYMeihuizi Yu
Meihuizi Yu
SLSitong Lei
Sitong Lei
WHWei Han
Wei Han
DSDongmei Shi
Dongmei Shi
This study primarily investigates the relationship between inflammatory hematological indices [neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), systemic immune inflammation index (SII), system inflammation response index (SIRI), and pan-immune inflammation value (PIV)] and acute coronary syndrome (ACS) in young patients, with secondary objectives to explore their association with coronary artery disease (CAD) severity and long-term prognosis. This observational study enrolled 986 CAD patients (aged 18–35 years) undergoing coronary angiography at Beijing Anzhen Hospital between January 2013 and December 2021. Participants were divided into ACS and non-ACS groups and further stratified by Gensini score into mild, moderate, and severe lesion groups. Patients were followed for a median of 8 years for major adverse cardiovascular events (MACE). Statistical analyses included Spearman correlation, ROC curves, and logistic regression to evaluate the relationships between inflammatory indices and ACS, coronary severity, and long-term outcomes. The prevalence of ACS progressively increased with higher quartiles of NLR, PLR, MLR, SII, SIRI, and PIV (P for trend <0.05). All indices were independently associated with ACS risk (P < 0.05), with ROC analysis indicating that SIRI (AUC = 0.720) and PIV (AUC = 0.721) had better predictive performance for ACS compared to other indices. NLR, MLR, and SIRI showed significant positive correlations with Gensini score and were independent predictors of coronary lesion severity (P<0.05). For long-term prognosis, smoking, familial hypercholesterolemia, higher Gensini score, and lower PLR were independent predictors of MACE, whereas other indices showed limited prognostic value. In young patients with CAD, SIRI and PIV are valuable for ACS prediction, and several indices correlate with lesion severity. However, their limited long-term prognostic utility suggests distinct pathological mechanisms may govern disease progression in this unique population.

1 April 2023 in Journal of Geriatric Cardiology
Verified
Journal Article
Closed access
PDF file
JSJia-Yin Sun
Jia-Yin Sun
CXChang-Bo Xuan
Chang-Bo Xuan
HYHai-Liang Yu
Hai-Liang Yu
HWHai-Yang Wang
Hai-Yang Wang
HHHong-Ya Han
Hong-Ya Han
SYShiwei Yang
Shiwei Yang
OBJECTIVE To access the efficacy and safety of the double-ProGlide technique for the femoral vein access-site closure in cryoballoon ablation with uninterrupted oral anticoagulants (OAC), and its impact on the electrophysiology laboratory time as well as hospital stay after the procedure in this observational study. METHODS Patients with atrial fibrillation undergoing cryoballoon ablation with uninterrupted OAC at Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China from May 2019 to May 2021 were enrolled in this study. From October 2020, double-ProGlide technique was consistently used for hemostasis (ProGlide group), and before that conventional manual compression was utilized (manual compression group). The occurrence of vascular and groin complications was accessed during the hospital stay and until the three-month follow-up. RESULTS A total of 140 participants (69.30% of male, mean age: 59.21 ± 10.29 years) were evaluated, 70 participants being in each group. Immediate hemostasis was achieved in all the patients with ProGlide closure. No major vascular complications were found in the ProGlide group while two major vascular complications were occurred in the manual compression group. The incidence of any groin complication was obviously higher in subjects with manual compression than patients with ProGlide devices (15.71% vs. 2.86%, P = 0.009). In addition, compared with the manual compression group, the ProGlide group was associated with significantly shorter total time in the electrophysiology laboratory [112.0 (93.3–128.8) min vs. 123.5 (107.3–158.3) min, P = 0.006], time from sheath removal until venous site hemostasis [3.8 (3.4–4.2) min vs. 8.0 (7.6–8.5) min, P < 0.001], bed rest time [8.0 (7.6–8.0) h vs. 14.1 (12.0–17.6) h, P < 0.001] and hospital stay after the procedure [13.8 (12.5–17.8) h vs. 38.0 (21.5–41.0) h, P < 0.001]. CONCLUSIONS Utilization of the double-ProGlide technique for hemostasis after cryoballoon ablation with uninterrupted OAC is feasible and safe, which has the clinical benefit in reducing the total electrophysiology laboratory time and the hospital stay length after the procedure.

19 October 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SYShiwei Yang
Shiwei Yang
Jiayin LiuJiayin Liu
Jiayin Liu
禹王禹凝 王
禹凝 王
菲赵菲 赵
菲 赵
WHWei Han
Wei Han
DSDongmei Shi
Dongmei Shi
Background: Rising coronary artery disease (CAD) in young adults calls for early risk stratification, yet the atherogenic index of plasma (AIP) has been understudied in patients aged ≤35 years. We therefore assessed its association with coronary lesion severity and major adverse cardiovascular events (MACE) in this cohort. Methods: This single-center retrospective study enrolled 948 patients aged 18–35 years with angiographically confirmed CAD. Greater coronary lesion severity was defined as a Gensini score > 40. The association between AIP and MACE was explored. Results: During a median follow-up of 60 months, MACE occurred in 287 patients. After full adjustment, AIP as a continuous variable was independently associated with greater coronary lesion severity (OR = 1.761; 95% CI: 1.052–2.948; p = 0.031). Regarding prognosis, when AIP was dichotomized at 0.4, it was independently associated with MACE (HR = 1.350; 95% CI: 1.060–1.721; p = 0.015) in the fully adjusted model, whereas continuous AIP did not retain significance. Restricted cubic spline analysis suggested a possible U-shaped dose–response relationship between AIP and MACE (overall p < 0.001, nonlinear p = 0.051). Subgroup analyses showed that the association of AIP with MACE was generally consistent across all examined strata, with no significant interactions (all p for interaction >0.05). Conclusions: AIP was independently associated with greater coronary lesion severity and MACE in young CAD patients (≤35 years). These findings support AIP as a practical tool not only for early risk stratification but also for guiding intensive lipid-lowering therapy in this distinct population.

4 July 2025 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
JSJiayin Sun
Jiayin Sun
JWJi Wu
Ji Wu
HYHailiang Yu
Hailiang Yu
DZDebao Zhang
Debao Zhang
HHHongya Han
Hongya Han
SYShiwei Yang
Shiwei Yang
Groin complications are considered to be the most common adverse events during cryoballon ablation. We aimed to compare the safety and cost-effectiveness of the LaPFOE technique (combined low approach femoral venous puncture, pre-dilation with a femoral artery sheath core, and figure-of-eight suture) with double-ProGlide technique and manual compression after cryoballoon ablation for atrial fibrillation with uninterrupted oral anticoagulants. Conventional manual compression, the double-ProGlide technique and the LaPFOE technique were applied in the first 100 patients, the following 92 patients, and the last 100 patients, respectively. The occurrence of groin complications was evaluated immediately and at the three-month follow-up. A total of 292 participants (71.23% male, mean age 60.48 ± 9.71 years) were enrolled. Major vascular complications were not observed in both the ProGlide group and the LaPFOE group, while three occurred in the manual compression group. The incidence of any groin complication was significantly greater in patients who underwent manual compression than in their counterparts who underwent either the ProGlide or LaPFOE technique [18 (18.00%) vs. 3 (3.26%) vs. 0 (0.0%); P < 0.05]. Compared with the manual compression group, both the ProGlide group and the LaPFOE group achieved faster hemostasis, earlier patient ambulation and shorter total electrophysiology laboratory time and hospital stay after the procedure (P < 0.001). The highest hospital cost was observed in the ProGlide group, whereas the lowest was shown in the LaPFOE group [10.53 (10.28, 10.63) ×104 yuan vs. 9.73 (9.47, 10.05) ×104 yuan vs. 9.55 (9.43, 9.66) ×104yuan, P < 0.05]. The LaPFOE technique is safe and cost-effective and has clinical benefits in lowering the occurrence of any groin complications, shortening the total electrophysiology laboratory time and hospital stay after the procedure and reducing hospital cost.